Literature DB >> 12612101

Preliminary estimates of human immunodeficiency virus prevalence and incidence among cocaine abusers of Porto Alegre, Brazil.

Flavio Pechansky1, Lisia von Diemen, Felix Kessler, Vania Hirakata, David Metzger, George E Woody.   

Abstract

A sample of 193 southern Brazilian inner-city cocaine abusers was studied to assess the prevalence of human immunodeficiency virus (HIV) infection. Following the exclusion of those who were seropositive from the intake sample, a cohort of 138 HIV-negative cocaine abusers was followed for 18 months to assess seroincidence rates and the associated characteristics. HIV status, drug use, sexual risk behaviors, and presence and severity of medical and psychiatric symptoms were collected at intake using a Brazilian version of the Risk Assessment Battery, the Addiction Severity Index (ASI), Symptom Check List-90 (SCL-90), and Beck Depression Inventory (BDI); this was repeated at 6-, 12-, and 18-month intervals. The overall seroprevalence was 28.5%, and the variables associated with HIV seropositivity were age older than 25 years, being single, having less than 8 years of education, and having injected cocaine at least once. Although follow-up procedures were difficult to implement due to sample characteristics, we obtained data from 82.6% of the participants for at least one follow-up and for 57% at all follow-up windows. Most participants showed high scores on the Beck Depression Inventory (mean of 20.6 +/- 13.9) and Symptom Check List-90 (mean of 106.4 +/- 91.9). There were 8 seroconversions in the 18-month period, yielding an incidence rate of 5.03/100 (confidence interval [CI] 2.2-9.7) person-years at risk. None of the seroconverters reported recent cocaine injection, and only 14.5% of the overall sample reported ever injecting cocaine, which suggests that another significant mode of transmission via sexual behavior should be considered as well. Each of these findings has important implications for the design of preventive interventions.

Entities:  

Mesh:

Year:  2003        PMID: 12612101      PMCID: PMC3456113          DOI: 10.1093/jurban/jtg115

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  16 in total

1.  Psychiatric disorders among drug dependent subjects: are they primary or secondary?

Authors:  W M Compton; L B Cottler; D L Phelps; A Ben Abdallah; E L Spitznagel
Journal:  Am J Addict       Date:  2000

2.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

3.  The SCL-90 and the MMPI: a step in the validation of a new self-report scale.

Authors:  L R Derogatis; K Rickels; A F Rock
Journal:  Br J Psychiatry       Date:  1976-03       Impact factor: 9.319

4.  Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro.

Authors:  E S Lima; S R Friedman; F I Bastos; P R Telles; P Friedmann; T P Ward; D C des Jarlais
Journal:  Addiction       Date:  1994-06       Impact factor: 6.526

5.  HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study.

Authors:  George E Woody; Robert Gallop; Lester Luborsky; Jack Blaine; Arlene Frank; Ihsan M Salloum; David Gastfriend; Paul Crits-Christoph
Journal:  J Acquir Immune Defic Syndr       Date:  2003-05-01       Impact factor: 3.731

6.  An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. WHO Collaborative Study Group.

Authors: 
Journal:  Bull Narc       Date:  1993

7.  Psychopathology among cocaine abusers entering treatment.

Authors:  P H Kleinman; A B Miller; R B Millman; G E Woody; T Todd; J Kemp; D S Lipton
Journal:  J Nerv Ment Dis       Date:  1990-07       Impact factor: 2.254

8.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

9.  Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.

Authors:  D S Metzger; G E Woody; A T McLellan; C P O'Brien; P Druley; H Navaline; D DePhilippis; P Stolley; E Abrutyn
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-09

10.  An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index.

Authors:  A T McLellan; L Luborsky; G E Woody; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1980-01       Impact factor: 2.254

View more
  7 in total

1.  Challenges in addressing depression in HIV research: assessment, cultural context, and methods.

Authors:  Jane M Simoni; Steven A Safren; Lisa E Manhart; Karen Lyda; Cynthia I Grossman; Deepa Rao; Matthew J Mimiaga; Frank Y Wong; Sheryl L Catz; Michael B Blank; Ralph DiClemente; Ira B Wilson
Journal:  AIDS Behav       Date:  2011-02

Review 2.  The globalization of addiction research: capacity-building mechanisms and selected examples.

Authors:  Richard A Rawson; George Woody; Thomas F Kresina; Steven Gust
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

3.  Socio-demographic Characteristics of Individuals with History of Crack Cocaine Use in the US General Population.

Authors:  Andriy Yur'yev; Evaristo Akerele
Journal:  Community Ment Health J       Date:  2015-03-22

Review 4.  HIV prevalence among female sex workers, drug users and men who have sex with men in Brazil: a systematic review and meta-analysis.

Authors:  Monica Malta; Monica M F Magnanini; Maeve B Mello; Ana Roberta P Pascom; Yohana Linhares; Francisco I Bastos
Journal:  BMC Public Health       Date:  2010-06-07       Impact factor: 3.295

Review 5.  Penn/VA center for studies of addiction.

Authors:  Charles P O'Brien; A Thomas McLellan; Anna Rose Childress; George E Woody
Journal:  Neuropharmacology       Date:  2008-06-26       Impact factor: 5.250

6.  Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience.

Authors:  Jordan E Lake; Ruth K Friedman; Cynthia B Cunha; Sandra W Cardoso; Valdilea G Veloso; Judith S Currier; Beatriz Grinsztejn
Journal:  HIV AIDS (Auckl)       Date:  2011-07-01

7.  Barriers and facilitators for men to attend prenatal care and obtain HIV voluntary counseling and testing in Brazil.

Authors:  Nava Yeganeh; Mariana Simon; Deborah Mindry; Karin Nielsen-Saines; Maria Cristina Chaves; Breno Santos; Marineide Melo; Brenna Mendoza; Pamina Gorbach
Journal:  PLoS One       Date:  2017-04-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.